No Prescription |
 |
 | ||
|
Prescription Drugs 14 |
|
| ||
No Prescription » Prescription Drugs 14
Restasis Eye Drops Generic Cyclosporine Rhinocort AqNasal Spray Rhinocort Aqua Rocephin IM Ceftriaxone Sodium Injection Selsun Blue 5 Anti Dandruff Shampoo Generic Selenium Sulphide Selsun Blue Deep Cleansing Generic Selenium Sulphide Selsun Blue Dual Action Generic Selenium Sulphide Selsun Treatment Genertic Selenium Sulphide SERETIDE ACCUHALER Advair Diskus Seroflo Inhaler Advair Inhaler SEROFLO MULTIHALER ACCUHALER Advair Diskus Seroflo Multihaler Advair Diskus
No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
|
|
|